This webinar is intended to provide guidance regarding the CGMPs on manufacturing methods utilizing the US FDA Production and Process Controls for Drugs and Devices and Statistical Process Controls (SPC) as taught by Drs. Demming and others and required also in the CGMPs and under control of variation process guidance.

This webinar will define what are the US FDA's expectation for the use of statistical tehniques, e.g., 21 CFr 820.25, for establishing, controlling , and verifying the acceptability of process capability and product characteristics, sampling plan justifications for product acceptance or validation and other studies. Increasingly regulatory agencies require trend analysis fo non-conformances, complaints, and CAPAs as part of CGMP compliance. Subject areas considered are:

• SPC in production, test and lab equipment
• Sampling plan justification
• Verifications and validations
• Trending: Non-conformances, complaints, and CAPAs

Why Should You Attend:

Statistical process control (SPC) is a method of quality control which employs statistical methods to monitor and control a process. It is one of the fifteen suboart requirements of the US FDA's QS Regulation, 21 CFR 82, the Medical Device CGMPS.

It can be a key tool in meeting the Production and Process Control (P&PC) requirements of those same CGMPs and those of the Drug CGMPs, 21 CFR 211. SPC used as prt of the requirements for P&PC in drug and device manufacturing under the CGMPs. They help to ensure that the process operates efficiently, producing more specification-conforming products with less waste (rework or scrap). SPC provides advantages in any production process where the "conforming product" (product meeting specifications) output can be measured.